Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.00859950859950863 0.00859950859950863
Stock impact report

AVITA Medical: Financial Challenges Ahead, Despite Innovative RECELL Device [Seeking Alpha]

Avita Medical, Inc. (RCEL) 
Company Research Source: Seeking Alpha
The RECELL device uses a patient's skin cells to create a spray-on suspension for healing and repigmentation. This procedure requires less donor skin and leads to faster wound recovery. RCEL's seemingly cheap P/S ratio is likely due to its operational inefficiency, which I don't think will improve in the near term. Despite its innovative technology, I deem RCEL a "hold" due to financial concerns. Management needs to focus on achieving profitability to avoid dilution. AVITA Medical, Inc. ( NASDAQ: RCEL ) specializes in regenerative medicine. It has an innovative device for skin restoration that treats full-thickness skin defects and vitiligo. RCEL's RECELL device uses a patient's skin cells to create a spray-on suspension to produce healing Recommended For You Recommended For You Show less Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RCEL alerts
Opt-in for
RCEL alerts

from News Quantified
Opt-in for
RCEL alerts

from News Quantified